Severine SIGRIST, PhD. President of Defymed®, she is also the head of the research department of the «Centre europeen d’etude du Diabète (CeeD)» since 2005, where she focuses on the discovery of innovative therapies for diabetes treatment. She has worked on the development of the MAILPAN® since more than ten years at the CeeD. She insures Defymed's development by searching for academic/industrial partners and seed funds, following the scientific development of the projects and managing the intellectual property of Defymed®.
Richard BOUAOUN, PhD. R&D Manager at DEFYMED®. After a doctorate in Molecular Biology applied to immunology, he followed master studies in innovative projects management at the Management School of Strasbourg. As a former project manager at the Alsace’s incubator, SEMIA, he followed up MAILPAN®’s project and has joined DEFYMED®’s team since March 2011. He is in charge of the coordination of MAILPAN®’s scientific program, the following of the clinical and regulatory affairs and the establishment of contract services with academics/SMEs/industrials.